Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Company Data

Name Creative Medical Technology Holdings, Inc. - Common Stock

Company Creative Medical Technology Holdings, Inc.

Symbol CELZ

Website https://www.creativemedicaltechnology.com

Primary Exchange

NASDAQ

ISIN US22529Y4089

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Timothy Warbington

Country United States of America

Currency USD

Employees 0,0 T

Address 211 East Osborn Road, 85012 Phoenix

IPO Date 2015-11-06

Ticker Symbols

Name	Symbol
NASDAQ	CELZ

More Shares

Investors who hold Creative Medical Technology Holdings, Inc. - Common Stock also have the following shares in their portfolio:

DRAGON FINANCE B.V. CLASS'C'SEC FLTG RTE NTS 13/07/23(REG S) Bond

PEXA AB SER.B Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog